NCT06752252

Brief Summary

The aim of the study is to compare postoperative analgesia in pediatric patients undergoing inguinal hernia repair by comparing the efficacy of ultrasound guided paravertebral block versus ultrasound guided erector spinae plane block.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
158

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2024

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 21, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 30, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

December 30, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

January 1, 2025

Status Verified

December 1, 2024

Enrollment Period

9 months

First QC Date

December 21, 2024

Last Update Submit

December 31, 2024

Conditions

Keywords

postoperative analgesiaultrasound guided paravertebral blockultrasound guided erector spinae plane blockinguinal hernia repair in pediatric

Outcome Measures

Primary Outcomes (1)

  • The total amount of rescue analgesia (Ibuprofen consumption)

    The total consumption of rescue analgesia (Ibuprofen consumption) postoperative

    for 24 hours postoperative

Secondary Outcomes (5)

  • Pain intensity at rest (static) and after movement or coughing (dynamic)

    0 minutes immediate postoperative ( on arrival to PACU), 30 minutes, 1hs, 2hs, 4hs, 8hs, 12 hrs and 24hs postoperatively

  • The time to first request of rescue analgesia (Ibuprofen)

    for 24 hours postoperative

  • The total number of patients requiring additional dose of intraoperative fentanyl.

    during operation period

  • To record the incidence of complications

    24 hours postoperative

  • Over all parent's satisfaction

    24 hours postoperative

Study Arms (3)

Group paravertebral (PVB) block

ACTIVE COMPARATOR

In the lateral decubitus and after sterilization and identifying the level of T10 ,linear ultrasound probe will be placed in the midline over the spinous process at the chosen level, then the probe will be moved laterally to view the lamina and hyperechoic transverse process ,the pleural should be visible as a bright white line .The needle should be inserted in -plane from lateral to medial and the needle tip should end in a hypoechoic triangular space .Correct needle placement should be confirmed by anterior displacement of pleura with injection of small volume of saline then 0.5 ml/kg of a mixture of 0.25 ℅ bupivacaine and 1℅ lidocaine (1:1) will be injected

Procedure: ultrasound guided paravertebral block

Group erector spinae plane (ESP) block

ACTIVE COMPARATOR

In the lateral decubitus position ,after sterilization, the linear ultrasound probe will be placed over transverse process of T10 ,after optimizing the image in sagittal or transverse scanning ,A 50 mm 22-G needle will be placed under the erector spinae muscle in -in plane orientation until it contacted T8 transverse process in the cranial caudal direction ,after hydro dissection and confirmation that the tip of the needle is between the transverse process and the fascia of the erector spinae muscle group, 0.5 ml/kg of a mixture of 0.25 ℅bupivacaine and 1℅ lidocaine (1:1) will be injected and the surgery will be started after 15 min

Procedure: Ultrasound guided erector spinae plane block

Control group (group C)

ACTIVE COMPARATOR

will receive standard general anesthesia with pain management protocol without regional block. Pain management protocol for all patients will include IV paracetamol 15 mg/kg every 6 hrs. (max dose for children \<50 kg is 60 mg/kg daily and if body weight ≥ 50 kg max dose is 4 gm daily) . Ibuprofen will be given as rescue analgesia 10 mg/kg IV if MOPS was \> 3 at rest or after movement and can be repeated every 6 hrs not exceeding 400 mg/dose and max daily dose 40 mg/kg.

Procedure: control group C

Interventions

after sterilization and identifying the level of T10 ,linear ultrasound probe will be placed in the midline over the spinous process at the chosen level, then the probe will be moved laterally to view the lamina and hyperechoic transverse process ,the pleural should be visible as a bright white line .The needle should be inserted in -plane from lateral to medial and the needle tip should end in a hypoechoic triangular space. Correct needle placement should be confirmed by anterior displacement of pleura with injection of small volume of saline then 0.5 ml/kg of a mixture of 0.25 ℅ bupivacaine and 1℅ lidocaine (1:1) will be injected

Group paravertebral (PVB) block

After sterilization, the linear ultrasound probe will be placed over transverse process of T10 ,after optimizing the image in sagittal or transverse scanning ,A 50 mm 22-G needle will be placed under the erector spinae muscle in -in plane orientation until it contacted T8 transverse process in the cranial caudal direction ,after hydro dissection and confirmation that the tip of the needle is between the transverse process and the fascia of the erector spinae muscle group, 0.5 ml/kg of a mixture of 0.25 ℅bupivacaine and 1℅ lidocaine (1:1) will be injected

Group erector spinae plane (ESP) block

will receive standard general anesthesia with pain management protocol without regional block.

Control group (group C)

Eligibility Criteria

Age24 Months - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Parents acceptance
  • \. Age: preschool and school age child (24 months-12 years old).
  • \. Sex: both sex (males or females).
  • \. Physical status: ASA 1\& II.
  • \. Type of operation: elective unilateral inguinal hernia repair

You may not qualify if:

  • Patient with any contraindications of regional blocks (as coagulopathy or local infection at injection site)
  • \. Patients with known history of allergy to the study drugs (bupivacaine and lidocaine).
  • \. Advanced hepatic, renal, cardiovascular, neurologic and respiratory diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

faculty of human medicine, Zagazig university hospitals

El Sharkia, Egypt

RECRUITING

Faculty of Human Medicine, Zagazig University

El Sharkia, Egypt

RECRUITING

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Dina Sadek Salem, MD

CONTACT

Fatima Ahmed, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
anesthetist not sharing in the study will assess patients
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Postoperative analgesia after inguinal hernia repair in pediatric by ultrasound guided paravertebral block or erector spinae block
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principle investigator

Study Record Dates

First Submitted

December 21, 2024

First Posted

December 30, 2024

Study Start

December 30, 2024

Primary Completion

September 30, 2025

Study Completion

December 30, 2025

Last Updated

January 1, 2025

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations